Allergic rhinoconjunctivitis
- PMID: 33004777
- PMCID: PMC8023069
- DOI: 10.23750/abm.v91i11-S.10310
Allergic rhinoconjunctivitis
Abstract
Allergic rhinitis (AR) is induced by an IgE-mediated immune reaction after allergen exposure. The typical symptoms are itching, nasal discharge, sneezing and nasal obstruction. The diagnosis is based on the concordance between allergic symptoms and diagnostic tests. The skin prick test (SPT) is recommended as the "gold standard" method. First generation H1-antihistamines are widely used for treatment of AR. Intranasal glucocorticosteroids are well tolerated and can be used also in paediatric age. Allergic rhinitis cannot be considered as an isolated pathology. Other atopic diseases (allergic conjunctivitis, atopic eczema, asthma) are commonly associated.
Conflict of interest statement
Each author declares that he or she has no commercial associations (e.g. consultancies, stock ownership, equity interest, patent/licensing arrangement etc.) that might pose a conflict of interest in connection with the submitted article
Figures
References
-
- Bousquet J, Pfaar O, Togias A, et al. 2019 ARIA Care pathways for allergen immunotherapy. Allergy. 2019;74:2087–2102. - PubMed
-
- Bousquet J, Heinzerling L, Bachert C, et al. Practical guide to skin prick tests in allergy to aeroallergens. Allergy. 2012;67:18–24. - PubMed
-
- Gelardi M, Iannuzzi L, Quaranta N, Landi M, Passalacqua G. NASAL cytology: practical aspects and clinical relevance. Clin Exp Allergy. 2016;46:785–792. - PubMed
-
- Miraglia Del Giudice M, Marseglia A, Leonardi S, et al. Allergic rhinitis and quality of life in children. Int J Immunopathol Pharmacol. 2011;24(4 Suppl):25–28. - PubMed
-
- Ciprandi G, Marseglia GL, Castagnoli R, et al. From IgE to clinical trials of allergic rhinitis. Expert Rev Clin Immunol. 2015;11:1321–1333. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
